Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban--an oral, direct factor Xa inhibitor--are not affected by aspirin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples